Andrea R Hagemann

6PUBLICATIONS
71CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 11, 2025
Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma.

Robert L Hollis, Austin Miller, Heather A Lankes

|Dec 02, 2025
Repositioning GLP-1 Receptor Agonists in Endometrial Cancer: Molecular Rationale, Preclinical Insights, and Translational Opportunities.

Vivek Podder, Robert L Coleman, Andrea R Hagemann

|Oct 03, 2025
Targeting RAD52 overcomes PARP inhibitor resistance in preclinical Brca2-deficient ovarian cancer model.

Yukihide Ota, Vijayalaxmi Gupta, Bisiayo E Fashemi

|Jul 22, 2025
Multiomic Characterization of Pre- and Post-Neoadjuvant Chemotherapy-Treated Ovarian Cancer Reveals Mediators of Tumorigenesis and Chemotherapy Response.

Mark C Valentine, Mary M Mullen, Emilee N Kotnik

|Aug 01, 2023
Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins.

Angela M Schab, Molly M Greenwade, Elizabeth Stock

|Apr 25, 2023
RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer.

Amanda J Compadre, Lillian N van Biljon, Mark C Valentine

Pageof 1

Frequent Collaborators

4 joint publications

Matthew A Powell

4 joint publications

Carolyn K McCourt

4 joint publications

Lindsay M Kuroki

3 joint publications

David G Mutch